Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pedro A Pury

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Physical Review. E, Statistical, Nonlinear, and Soft Matter Physics|October 26, 2005
Multifractal spectra of mean first-passage-time distributions in disordered chainsPedro A Pury, Manuel O Cáceres
Physical Review. E, Statistical, Nonlinear, and Soft Matter Physics|September 21, 2002
Survival and residence times in disordered chains with biasPedro A Pury, Manuel O Cáceres
Physical Review. E, Statistical, Nonlinear, and Soft Matter Physics|March 17, 2011
Intermittent pathways towards a dynamical targetFélix Rojo, Pedro A Pury, Carlos E Budde
Viruses|January 19, 2018
Biomarkers of Progression after HIV Acute/Early Infection: Nothing Compares to CD4⁺ T-cell Count?Gabriela Turk, Yanina Ghiglione, Macarena Hormanstorfer, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Physical Review. E, Statistical, Nonlinear, and Soft Matter Physics|October 26, 2005
Multifractal spectra of mean first-passage-time distributions in disordered chainsPedro A Pury, Manuel O Cáceres
Physical Review. E, Statistical, Nonlinear, and Soft Matter Physics|September 21, 2002
Survival and residence times in disordered chains with biasPedro A Pury, Manuel O Cáceres
Physical Review. E, Statistical, Nonlinear, and Soft Matter Physics|March 17, 2011
Intermittent pathways towards a dynamical targetFélix Rojo, Pedro A Pury, Carlos E Budde
Viruses|January 19, 2018
Biomarkers of Progression after HIV Acute/Early Infection: Nothing Compares to CD4⁺ T-cell Count?Gabriela Turk, Yanina Ghiglione, Macarena Hormanstorfer, et al.
Pageof 1